Utilization of Health Care Among Female-to-Male Transgender Individuals in the United States
- 14 May 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Homosexuality
- Vol. 54 (3) , 243-258
- https://doi.org/10.1080/00918360801982124
Abstract
Female-To-Male (FTM) transgender individuals were approached at a conference and several peer support groups in the United States and asked to complete a short questionnaire regarding their medical care. Results from the 122 completed questionnaires indicated that a high number of respondents were taking testosterone (n = 106) and had some gender-confirming surgery (n = 68). Seventy percent of respondents rated their overall quality of health care “good” or “excellent.” A surprising finding was the low number (7%) reporting diagnoses of polycystic ovarian syndrome–the incidence of which has been reported elsewhere as high as 50%. Also notable were the high levels of employment, insurance, knowledge of standards of care, and access to providers, contrasting with reports from studies involving predominantly Male-To-Female (MTF) individuals. Finally, FTM's usage of transition-related medical resources can vary, but many within this study are foregoing genital surgery.Keywords
This publication has 13 references indexed in Scilit:
- Female-to-male transgender quality of lifeQuality of Life Research, 2006
- Health and Social Service Needs of Transgender People in ChicagoInternational Journal of Transgenderism, 2005
- The Health and Social Service Needs of Transgender People in PhiladelphiaInternational Journal of Transgenderism, 2005
- Evaluation of a sexual health approach to reducing HIV/STD risk in the transgender communityAIDS Care, 2005
- Enhancing transgender health careAmerican Journal of Public Health, 2001
- Trans health crisis: for us it's life or deathAmerican Journal of Public Health, 2001
- 17β‐Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals*Clinical Endocrinology, 1992
- Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?Histopathology, 1991
- Histopathological Effects of Exogenously Administered Testosterone in 19 Female to Male TranssexualsJournal of Clinical Endocrinology & Metabolism, 1986
- Health professionals' factual knowledge and changing attitudes toward transsexualsSocial Science & Medicine, 1986